Physician profile
Avani Dave
NPI 1285157966
$121,759.74
in general payments reported to CMS, 2019-2025
16 companies · $78K in 2025
The $78K reported for 2025 was more than what 99% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $37.51 · 2021: $344 · 2022: $576 · 2023: $6,308 · 2024: $36K · 2025: $78K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $82K · Travel and Lodging: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $5,956 · Consulting Fee: $1,425 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $82,027.00 |
| Travel and Lodging | $15,741.57 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,275.00 |
| Food and Beverage | $5,956.30 |
| Consulting Fee | $1,425.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $100,416.06 | 2022-2025 | Miebo, Xiidra, Zenlens |
| Tarsus Pharmaceuticals, INC. | $17,996.33 | 2025 | Xdemvy |
| Abbvie INC. | $1,000.52 | 2022-2023 | Vuity |
| Alcon Vision LLC | $403.65 | 2020-2025 | Eysuvis, Tryptyr, Clareon Panoptix Pro |
| Allergan, INC. | $364.99 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $246.48 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $207.53 | 2022-2024 | Acuvue |
| Sight Sciences, INC. | $199.25 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $186.06 | 2022-2025 | Cequa |
| Coopervision INC. | $174.09 | 2023-2025 | Onefit Contact Lens |
| Horizon Therapeutics Plc | $124.99 | 2023 | Tepezza |
| Oyster Point Pharma, INC. | $124.99 | 2022 | |
| Thea Pharma INC. | $120.09 | 2025 | Iyuzeh |
| Rxsight INC | $107.26 | 2023-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Harrow Eye, LLC | $73.33 | 2025 | Vevye |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avani Dave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.